{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:30:34Z","timestamp":1792290634878,"version":"4.4.0"},"reference-count":130,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.2215\/cjn.06230614","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T02:48:21Z","timestamp":1420685301000},"page":"1636-1650","source":"Crossref","is-referenced-by-count":271,"title":["Molecules Great and Small"],"prefix":"10.2215","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct01403389","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01919346","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01327573","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Douglas R.","family":"Mathern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Heeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20230601","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.122.1.99","article-title":"A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis","volume":"122","author":"Cochrane","year":"1965","journal-title":"J Exp Med"},{"key":"R2-19-20230601","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI115314","article-title":"Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells","volume":"88","author":"Brooimans","year":"1991","journal-title":"J Clin Invest"},{"key":"R3-19-20230601","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jlb.41.4.295","article-title":"Complement component C3 secretion by mouse macrophage-like cell lines","volume":"41","author":"Goodrum","year":"1987","journal-title":"J Leukoc Biol"},{"key":"R4-19-20230601","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: A key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"R5-19-20230601","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.1248943","article-title":"Complement is activated by IgG hexamers assembled at the cell surface","volume":"343","author":"Diebolder","year":"2014","journal-title":"Science"},{"key":"R6-19-20230601","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4049\/jimmunol.179.4.2600","article-title":"Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly","volume":"179","author":"Spitzer","year":"2007","journal-title":"J Immunol"},{"key":"R7-19-20230601","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1084\/jem.142.4.856","article-title":"Properdin: Binding to C3b and stabilization of the C3b-dependent C3 convertase","volume":"142","author":"Fearon","year":"1975","journal-title":"J Exp Med"},{"key":"R8-19-20230601","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1161\/CIRCULATIONAHA.113.002972","article-title":"Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-\u03baB signaling in endothelial cells","volume":"128","author":"Jane-Wit","year":"2013","journal-title":"Circulation"},{"key":"R9-19-20230601","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1172\/JCI112372","article-title":"Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells","volume":"77","author":"Adler","year":"1986","journal-title":"J Clin Invest"},{"key":"R10-19-20230601","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5a in inflammatory responses","volume":"23","author":"Guo","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R11-19-20230601","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1084\/jem.20121525","article-title":"Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells","volume":"210","author":"Kwan","year":"2013","journal-title":"J Exp Med"},{"key":"R12-19-20230601","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.4049\/jimmunol.1300847","article-title":"Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells","volume":"190","author":"van der Touw","year":"2013","journal-title":"J Immunol"},{"key":"R13-19-20230601","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol Immunol"},{"key":"R14-19-20230601","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1084\/jem.166.5.1221","article-title":"The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb","volume":"166","author":"Fujita","year":"1987","journal-title":"J Exp Med"},{"key":"R15-19-20230601","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1084\/jem.160.5.1558","article-title":"Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes","volume":"160","author":"Medof","year":"1984","journal-title":"J Exp Med"},{"key":"R16-19-20230601","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1073\/pnas.82.3.859","article-title":"Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines","volume":"82","author":"Cole","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-19-20230601","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1084\/jem.181.1.151","article-title":"Mouse complement regulatory protein Crry\/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein","volume":"181","author":"Kim","year":"1995","journal-title":"J Exp Med"},{"key":"R18-19-20230601","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-065X.2001.1800103.x","article-title":"Structure and biology of complement protein C3, a connecting link between innate and acquired immunity","volume":"180","author":"Sahu","year":"2001","journal-title":"Immunol Rev"},{"key":"R19-19-20230601","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.141.8.2569","article-title":"CR2 ligands modulate human B cell activation","volume":"141","author":"Bohnsack","year":"1988","journal-title":"J Immunol"},{"key":"R20-19-20230601","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1021\/bi4003452","article-title":"Functional anatomy of complement factor H","volume":"52","author":"Makou","year":"2013","journal-title":"Biochemistry"},{"key":"R21-19-20230601","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1046\/j.1523-1755.1999.00722.x","article-title":"C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor","volume":"56","author":"Peake","year":"1999","journal-title":"Kidney Int"},{"key":"R22-19-20230601","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2008-04-151068","article-title":"Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis","volume":"112","author":"Lalli","year":"2008","journal-title":"Blood"},{"key":"R23-19-20230601","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1084\/jem.20041967","article-title":"Decay-accelerating factor modulates induction of T cell immunity","volume":"201","author":"Heeger","year":"2005","journal-title":"J Exp Med"},{"key":"R24-19-20230601","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","article-title":"Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells","volume":"28","author":"Strainic","year":"2008","journal-title":"Immunity"},{"key":"R25-19-20230601","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1084\/jem.140.1.126","article-title":"Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses","volume":"140","author":"Pepys","year":"1974","journal-title":"J Exp Med"},{"key":"R26-19-20230601","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"R27-19-20230601","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/ajt.12405","article-title":"Immune cell-derived C3a and C5a costimulate human T cell alloimmunity","volume":"13","author":"Cravedi","year":"2013","journal-title":"Am J Transplant"},{"key":"R28-19-20230601","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.immuni.2013.10.018","article-title":"Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation","volume":"39","author":"Liszewski","year":"2013","journal-title":"Immunity"},{"key":"R29-19-20230601","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"R30-19-20230601","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ni.2499","article-title":"Absence of signaling into CD4* cells via C3aR and C5aR enables autoinductive TGF-\u03b21 signaling and induction of Foxp3* regulatory T cells","volume":"14","author":"Strainic","year":"2013","journal-title":"Nat Immunol"},{"key":"R31-19-20230601","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature01315","article-title":"Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype","volume":"421","author":"Kemper","year":"2003","journal-title":"Nature"},{"key":"R32-19-20230601","first-page":"455","article-title":"Analytical pathology. III. New observations on the pathogenesis of glomerulonephritis, lipid nephrosis, periarteritis nodosa, and secondary amyloidosis in man","volume":"32","author":"Mellors","year":"1956","journal-title":"Am J Pathol"},{"key":"R33-19-20230601","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/ajcp\/32.2.109","article-title":"The fine structure of the glomerulus in membranous glomerulonephritis (lipoid nephrosis) in adults","volume":"32","author":"Movat","year":"1959","journal-title":"Am J Clin Pathol"},{"key":"R34-19-20230601","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"R35-19-20230601","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R36-19-20230601","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10157-007-0496-1","article-title":"C4d Immunohistochemistry in glomerulonephritis with different antibodies","volume":"11","author":"Suzuki","year":"2007","journal-title":"Clin Exp Nephrol"},{"key":"R37-19-20230601","first-page":"1391","article-title":"C4d immunohistochemical staining is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in membranous glomerulonephritis","volume":"26","author":"Val-Bernal","year":"2011","journal-title":"Histol Histopathol"},{"key":"R38-19-20230601","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.semnephrol.2013.08.004","article-title":"The role of complement in membranous nephropathy","volume":"33","author":"Ma","year":"2013","journal-title":"Semin Nephrol"},{"key":"R39-19-20230601","first-page":"185","article-title":"Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats","volume":"135","author":"Baker","year":"1989","journal-title":"Am J Pathol"},{"key":"R40-19-20230601","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1046\/j.1523-1755.2003.00305.x","article-title":"Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy","volume":"64","author":"Saran","year":"2003","journal-title":"Kidney Int"},{"key":"R41-19-20230601","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1681\/ASN.V134946","article-title":"Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy","volume":"13","author":"Yuan","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R42-19-20230601","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ki.1992.321","article-title":"Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy","volume":"42","author":"Floege","year":"1992","journal-title":"Kidney Int"},{"key":"R43-19-20230601","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.1016\/S0021-9258(18)37714-7","article-title":"Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV","volume":"263","author":"Saus","year":"1988","journal-title":"J Biol Chem"},{"key":"R44-19-20230601","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(01)06077-9","article-title":"Goodpasture\u2019s disease","volume":"358","author":"Salama","year":"2001","journal-title":"Lancet"},{"key":"R45-19-20230601","doi-asserted-by":"crossref","first-page":"e91250","DOI":"10.1371\/journal.pone.0091250","article-title":"The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease","volume":"9","author":"Ma","year":"2014","journal-title":"PLoS ONE"},{"key":"R46-19-20230601","first-page":"207","article-title":"Augmented expression of glomerular basement membrane specific type IV collagen isoforms (alpha3-alpha5) in experimental membranous nephropathy","volume":"110","author":"Minto","year":"1998","journal-title":"Proc Assoc Am Physicians"},{"key":"R47-19-20230601","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/ndt\/13.11.2799","article-title":"Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria","volume":"13","author":"H\u00e9bert","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R48-19-20230601","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1681\/ASN.2010060647","article-title":"Complement factor H deficiency accelerates development of lupus nephritis","volume":"22","author":"Bao","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R49-19-20230601","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.180.2.1231","article-title":"Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL\/lpr mice","volume":"180","author":"Atkinson","year":"2008","journal-title":"J Immunol"},{"key":"R50-19-20230601","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/eji.200526327","article-title":"C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist","volume":"35","author":"Bao","year":"2005","journal-title":"Eur J Immunol"},{"key":"R51-19-20230601","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1073\/pnas.93.16.8563","article-title":"Amelioration of lupus-like autoimmune disease in NZB\/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5","volume":"93","author":"Wang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R52-19-20230601","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2011.07.006","article-title":"Emerging biological drugs: A new therapeutic approach for systemic lupus erythematosus. An update upon efficacy and adverse events","volume":"11","author":"Murdaca","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R53-19-20230601","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1126\/science.279.5353.1052","article-title":"Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis","volume":"279","author":"Clynes","year":"1998","journal-title":"Science"},{"key":"R54-19-20230601","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/eji.200636719","article-title":"Elevated levels of endogenous apoptotic DNA and IFN-alpha in complement C4-deficient mice: Implications for induction of systemic lupus erythematosus","volume":"37","author":"Finke","year":"2007","journal-title":"Eur J Immunol"},{"key":"R55-19-20230601","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1756-185X.2010.01574.x","article-title":"Impact of C1q deficiency on the severity and outcome of childhood systemic lupus erythematosus","volume":"14","author":"Al-Mayouf","year":"2011","journal-title":"Int J Rheum Dis"},{"key":"R56-19-20230601","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-pathol-011811-132453","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis","volume":"8","author":"Jennette","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"R57-19-20230601","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s10875-008-9268-2","article-title":"Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis","volume":"29","author":"Xing","year":"2009","journal-title":"J Clin Immunol"},{"key":"R58-19-20230601","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"R59-19-20230601","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.ki.5002103","article-title":"Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice","volume":"71","author":"Huugen","year":"2007","journal-title":"Kidney Int"},{"key":"R60-19-20230601","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2013020143","article-title":"C5a receptor (CD88) blockade protects against MPO-ANCA GN","volume":"25","author":"Xiao","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R61-19-20230601","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1681\/ASN.2008050497","article-title":"C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis","volume":"20","author":"Schreiber","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R62-19-20230601","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2011030304","article-title":"Basic and translational concepts of immune-mediated glomerular diseases","volume":"23","author":"Couser","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R63-19-20230601","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1681\/ASN.2012020187","article-title":"IgM contributes to glomerular injury in FSGS","volume":"24","author":"Strassheim","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R64-19-20230601","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.ajkd.2012.04.011","article-title":"Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factor H and C3","volume":"60","author":"Sethi","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R65-19-20230601","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1172\/JCI36000","article-title":"Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells","volume":"119","author":"Bao","year":"2009","journal-title":"J Clin Invest"},{"key":"R66-19-20230601","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.semnephrol.2011.06.008","article-title":"Infection-related glomerulonephritis: Understanding mechanisms","volume":"31","author":"Nadasdy","year":"2011","journal-title":"Semin Nephrol"},{"key":"R67-19-20230601","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ki.2012.384","article-title":"Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement","volume":"83","author":"Sethi","year":"2013","journal-title":"Kidney Int"},{"key":"R68-19-20230601","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.175.4.939","article-title":"Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis","volume":"175","author":"Meri","year":"1992","journal-title":"J Exp Med"},{"key":"R69-19-20230601","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/TP.0b013e3181a44206","article-title":"Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts","volume":"87","author":"Lachmann","year":"2009","journal-title":"Transplantation"},{"key":"R70-19-20230601","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1600-6143.2010.03065.x","article-title":"Antibody-mediated rejection: Emergence of animal models to answer clinical questions","volume":"10","author":"Baldwin","year":"2010","journal-title":"Am J Transplant"},{"key":"R71-19-20230601","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"R72-19-20230601","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00007890-199501000-00023","article-title":"The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat","volume":"59","author":"Brauer","year":"1995","journal-title":"Transplantation"},{"key":"R73-19-20230601","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0002-9440(10)65231-5","article-title":"C6 produced by macrophages contributes to cardiac allograft rejection","volume":"155","author":"Qian","year":"1999","journal-title":"Am J Pathol"},{"key":"R74-19-20230601","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.4049\/jimmunol.179.7.4451","article-title":"Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation","volume":"179","author":"Wang","year":"2007","journal-title":"J Immunol"},{"key":"R75-19-20230601","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"R76-19-20230601","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-6143.2008.02451.x","article-title":"The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"},{"key":"R77-19-20230601","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/TP.0b013e3182888db6","article-title":"The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes","volume":"95","author":"Freitas","year":"2013","journal-title":"Transplantation"},{"key":"R78-19-20230601","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"R79-19-20230601","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1681\/ASN.V10102208","article-title":"Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries","volume":"10","author":"Collins","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R80-19-20230601","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.177.2.517","article-title":"Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria","volume":"177","author":"Takahashi","year":"1993","journal-title":"J Exp Med"},{"key":"R81-19-20230601","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med"},{"key":"R82-19-20230601","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1056\/NEJMc1010351","article-title":"Paroxysmal nocturnal hemoglobinuria\u2014hemolysis before and after eculizumab","volume":"363","author":"Risitano","year":"2010","journal-title":"N Engl J Med"},{"key":"R83-19-20230601","first-page":"273","article-title":"Compstatin: A complement inhibitor on its way to clinical application","volume":"632","author":"Ricklin","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"R84-19-20230601","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.semnephrol.2013.08.002","article-title":"Dense deposit disease and C3 glomerulopathy","volume":"33","author":"Barbour","year":"2013","journal-title":"Semin Nephrol"},{"key":"R85-19-20230601","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat Genet"},{"key":"R86-19-20230601","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.molimm.2009.03.030","article-title":"Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase","volume":"46","author":"Paix\u00e3o-Cavalcante","year":"2009","journal-title":"Mol Immunol"},{"key":"R87-19-20230601","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.0601094103","article-title":"Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice","volume":"103","author":"Pickering","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R88-19-20230601","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.ki.5000269","article-title":"Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)","volume":"70","author":"Licht","year":"2006","journal-title":"Kidney Int"},{"key":"R89-19-20230601","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMc1112273","article-title":"Eculizumab in a patient with dense-deposit disease","volume":"366","author":"Daina","year":"2012","journal-title":"N Engl J Med"},{"key":"R90-19-20230601","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMc1111953","article-title":"Eculizumab for the treatment of dense-deposit disease","volume":"366","author":"Vivarelli","year":"2012","journal-title":"N Engl J Med"},{"key":"R91-19-20230601","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","article-title":"Translational mini-review series on complement factor H: Renal diseases associated with complement factor H: Novel insights from humans and animals","volume":"151","author":"Pickering","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"R92-19-20230601","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol"},{"key":"R93-19-20230601","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R94-19-20230601","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2010050451","article-title":"The development of atypical hemolytic uremic syndrome depends on complement C5","volume":"22","author":"de Jorge","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R95-19-20230601","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J Exp Med"},{"key":"R96-19-20230601","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.1019338108","article-title":"Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk","volume":"108","author":"Heurich","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R97-19-20230601","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ajkd.2012.02.329","article-title":"Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency","volume":"60","author":"Vernon","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R98-19-20230601","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R99-19-20230601","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1600-6143.2011.03754.x","article-title":"Delayed graft function in the kidney transplant","volume":"11","author":"Siedlecki","year":"2011","journal-title":"Am J Transplant"},{"key":"R100-19-20230601","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nri3225","article-title":"The role of complement in the early immune response to transplantation","volume":"12","author":"Sacks","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R101-19-20230601","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1096\/fj.05-4747com","article-title":"Local extravascular pool of C3 is a determinant of postischemic acute renal failure","volume":"20","author":"Farrar","year":"2006","journal-title":"FASEB J"},{"key":"R102-19-20230601","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2011111072","article-title":"C3a and C5a promote renal ischemia-reperfusion injury","volume":"23","author":"Peng","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R103-19-20230601","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/TP.0b013e31827e31c9","article-title":"Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation","volume":"95","author":"de Vries","year":"2013","journal-title":"Transplantation"},{"key":"R104-19-20230601","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1681\/ASN.2008111145","article-title":"Expression of complement components differs between kidney allografts from living and deceased donors","volume":"20","author":"Naesens","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R105-19-20230601","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1681\/ASN.2005101116","article-title":"Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage","volume":"17","author":"Patel","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R106-19-20230601","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0272-6386(99)70273-8","article-title":"Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion","volume":"33","author":"Monaco","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R107-19-20230601","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1681\/ASN.2012040390","article-title":"Mechanisms and treatment of CKD","volume":"23","author":"Ruggenenti","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R108-19-20230601","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1096\/fj.07-8719com","article-title":"Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury","volume":"22","author":"Sheerin","year":"2008","journal-title":"FASEB J"},{"key":"R109-19-20230601","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1681\/ASN.2008040434","article-title":"C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy","volume":"20","author":"Tang","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R110-19-20230601","doi-asserted-by":"crossref","first-page":"F957","DOI":"10.1152\/ajprenal.00344.2013","article-title":"Complement 3 activates the renal renin-angiotensin system by induction of epithelial-to-mesenchymal transition of the nephrotubulus in mice","volume":"305","author":"Zhou","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"R111-19-20230601","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1681\/ASN.2006121343","article-title":"Complement C5 mediates experimental tubulointerstitial fibrosis","volume":"18","author":"Boor","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R112-19-20230601","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1523-1755.2005.67106.x","article-title":"C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria","volume":"67","author":"Rangan","year":"2005","journal-title":"Kidney Int"},{"key":"R113-19-20230601","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1093\/ndt\/gfr025","article-title":"Association of complement 5 genetic polymorphism with renal allograft outcomes in Korea","volume":"26","author":"Jeong","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R114-19-20230601","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa052825","article-title":"Influence of donor C3 allotype on late renal-transplantation outcome","volume":"354","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"R115-19-20230601","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJMoa0801861","article-title":"C3 polymorphisms and allograft outcome in renal transplantation","volume":"360","author":"Varagunam","year":"2009","journal-title":"N Engl J Med"},{"key":"R116-19-20230601","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1681\/ASN.2009060628","article-title":"Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies","volume":"21","author":"Nakorchevsky","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R117-19-20230601","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nm0602-582","article-title":"Local synthesis of complement component C3 regulates acute renal transplant rejection","volume":"8","author":"Pratt","year":"2002","journal-title":"Nat Med"},{"key":"R118-19-20230601","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.4049\/jimmunol.181.7.4580","article-title":"Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection","volume":"181","author":"Pavlov","year":"2008","journal-title":"J Immunol"},{"key":"R119-19-20230601","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ajpath.2011.04.038","article-title":"Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection","volume":"179","author":"Vieyra","year":"2011","journal-title":"Am J Pathol"},{"key":"R120-19-20230601","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2009.02961.x","article-title":"Decay accelerating factor is essential for successful corneal engraftment","volume":"10","author":"Esposito","year":"2010","journal-title":"Am J Transplant"},{"key":"R121-19-20230601","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/j.1600-6143.2009.02723.x","article-title":"Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation","volume":"9","author":"Raedler","year":"2009","journal-title":"Am J Transplant"},{"key":"R122-19-20230601","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1681\/ASN.2007111267","article-title":"C5a receptor inhibition improves renal allograft survival","volume":"19","author":"Gueler","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R123-19-20230601","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1600-6143.2011.03561.x","article-title":"Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice","volume":"11","author":"Raedler","year":"2011","journal-title":"Am J Transplant"},{"key":"R124-19-20230601","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imbio.2011.07.033","article-title":"Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a","volume":"217","author":"Li","year":"2012","journal-title":"Immunobiology"},{"key":"R125-19-20230601","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.4049\/jimmunol.165.11.6599","article-title":"Activated human T lymphocytes express a functional C3a receptor","volume":"165","author":"Werfel","year":"2000","journal-title":"J Immunol"},{"key":"R126-19-20230601","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.4049\/jimmunol.162.7.4018","article-title":"Human T cells express the C5a receptor and are chemoattracted to C5a","volume":"162","author":"Nataf","year":"1999","journal-title":"J Immunol"},{"key":"R127-19-20230601","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0006-8993(01)02003-0","article-title":"Expression of the anaphylatoxin C5a receptor in the oligodendrocyte lineage","volume":"894","author":"Nataf","year":"2001","journal-title":"Brain Res"},{"key":"R128-19-20230601","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/TP.0b013e3181889831","article-title":"Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury","volume":"86","author":"Keslar","year":"2008","journal-title":"Transplantation"},{"key":"R129-19-20230601","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.4049\/jimmunol.1203200","article-title":"Complement in immune and inflammatory disorders: Therapeutic interventions","volume":"190","author":"Ricklin","year":"2013","journal-title":"J Immunol"},{"key":"R130-19-20230601","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201509000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:57Z","timestamp":1786369497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201509000-00019"}},"subtitle":["The Complement System"],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":130,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.06230614","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}